Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Earnings for Prenetics Global Limited (PRE)
Earnings in 2023 (TTM): $-56,669,031
According to Prenetics Global Limited's latest financial reports the company's current earnings (TTM) are $-56,669,031. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Prenetics Global Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-56,669,031 | $-62,723,871 |
| 2022 | $-183,306,283 | $-190,453,387 |
| 2021 | $-170,284,098 | $-174,016,842 |
| 2020 | $-3,901,443 | $-1,963,885 |
| 2019 | $-20,872,675 | $-20,195,201 |